These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 38164933)
61. Anorectal Mpox in men who have sex with men associated with sexually transmitted co-infections: a case series. Russell A; Siddiq M; Fitzpatrick C; Richardson D Sex Transm Infect; 2024 Jan; 100(1):52-53. PubMed ID: 37833058 [No Abstract] [Full Text] [Related]
62. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257 [TBL] [Abstract][Full Text] [Related]
63. [Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]. Schmidt D; Kollan C; Schewe K; Hanhoff N; Rüsenberg R; Friebe M; Schikowski T; Schink SB; Marcus U; Koppe U; Jansen K; Streeck H; Ottensmeyer P; An der Heiden M; Bannert N; M'Bayo R; Ceres M; Weber L; Sweers H; Schmidt AJ; Tietz H; Danan E; Bendig J; Kloep S; Neumann A; Valbert F; Wasem J; Bartmeyer B; Bremer V; Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1008-1018. PubMed ID: 37436444 [TBL] [Abstract][Full Text] [Related]
64. Is Mpox a Sexually Transmitted Infection? Why Narrowing the Scope of This Disease May Be Harmful. Hazra A; Cherabie JN Clin Infect Dis; 2023 Apr; 76(8):1504-1507. PubMed ID: 36546644 [TBL] [Abstract][Full Text] [Related]
65. Brief Report: Use of Remnant Specimens to Assess Use of HIV PrEP Among Populations With Risk of HIV Infection: A Novel Approach. Pathela P; Qasmieh S; Gandhi M; Rozen E; Okochi H; Goldstein H; Herold BC; Jamison K; Schillinger JA; Nash D J Acquir Immune Defic Syndr; 2022 Aug; 90(4):382-387. PubMed ID: 35357337 [TBL] [Abstract][Full Text] [Related]
66. Mpox Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May-September 2022 International Outbreak. Martínez de Victoria-Carazo J; García-Ceberino PM; de Salazar-González A; Faro-Míguez N; Fuentes-López A; Viñuela-González L; Palomares-Rodríguez J; Valero-Ubierna C; Ruíz-Villaverde R; García-García F; Hernández-Quero J; Ruíz-Sancho AL AIDS Res Hum Retroviruses; 2023 Nov; 39(11):604-609. PubMed ID: 37450341 [TBL] [Abstract][Full Text] [Related]
67. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis. Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501 [TBL] [Abstract][Full Text] [Related]
68. Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe. Kowalski J; Cielniak I; Garbacz-Łagożna E; Cholewińska-Szymańska G; Parczewski M J Med Virol; 2023 Oct; 95(10):e29172. PubMed ID: 37861345 [TBL] [Abstract][Full Text] [Related]
69. Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System. Schmidt MA; Dickerson JF; O'Keeffe-Rosetti MC; Salas SB; Donald JL; Tao G Sex Transm Dis; 2022 Sep; 49(9):616-621. PubMed ID: 35724111 [TBL] [Abstract][Full Text] [Related]
70. Receptiveness to monkeypox vaccines and public health communication strategies among gay, bisexual and other men who have sex with men in Singapore: cross-sectional quantitative and qualitative insights. Chan ZYS; Chong SY; Niaupari S; Harrison-Quintana J; Lim JT; Dickens B; Kularathne Y; Wong CS; Tan RKJ Sex Transm Infect; 2024 Aug; 100(6):362-367. PubMed ID: 38821878 [TBL] [Abstract][Full Text] [Related]
71. Bacterial sexually transmitted infections are concentrated in subpopulations of men who have sex with men using HIV pre-exposure prophylaxis. Jongen VW; Van Der Loeff MFS; Van Den Elshout M; Wijstma E; Coyer L; Davidovich U; De Vries HJC; Prins M; Hoornenborg E; Boyd A AIDS; 2023 Nov; 37(13):2059-2068. PubMed ID: 37503635 [TBL] [Abstract][Full Text] [Related]
73. A qualitative study of Chicago gay men and the Mpox outbreak of 2022 in the context of HIV/AIDS, PrEP, and COVID-19. Hughes D; Ai J; Vazirnia P; McLeish T; Krajco C; Moraga R; Quinn K BMC Infect Dis; 2024 Oct; 24(1):1174. PubMed ID: 39425023 [TBL] [Abstract][Full Text] [Related]
74. Concomitant Utilization of Pre-Exposure Prophylaxis (PrEP) and Meningococcal Vaccine (MenACWY) Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles County, California. Holloway IW; Tan D; Bednarczyk RA; Fenimore VL; Randall L; Lutz CS; Frew PM Arch Sex Behav; 2020 Jan; 49(1):137-146. PubMed ID: 31628630 [TBL] [Abstract][Full Text] [Related]
75. Prior Sexually Transmitted Infections and HIV in Patients With Mpox, Chicago, Illinois (June 2022-March 2023). Faherty EAG; Holly T; Herrera K; Guidry T; Lyang J; Black S; Tabidze I J Infect Dis; 2024 Mar; 229(Supplement_2):S197-S202. PubMed ID: 37947018 [TBL] [Abstract][Full Text] [Related]
76. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study. Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248 [TBL] [Abstract][Full Text] [Related]
77. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study. Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169 [TBL] [Abstract][Full Text] [Related]
78. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention. Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546 [TBL] [Abstract][Full Text] [Related]
79. Sexual behavior and drug use impact in gay, bisexual, and other men who have sex with men. García-Pérez JN; Cañas-Ruano E; Navarro J; Raventós B; López L; Broto C; Arando M; Barberá MJ; Descalzo V; Suanzes P; Burgos J; Curran A; Falcó V Med Clin (Barc); 2022 Dec; 159(12):563-568. PubMed ID: 35725636 [TBL] [Abstract][Full Text] [Related]
80. Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States-National HIV Behavioral Surveillance, 5 US Cities, 2017. Chapin-Bardales J; Johnson Jones ML; Kirkcaldy RD; Bernstein KT; Paz-Bailey G; Phillips C; Papp JR; Raymond HF; Opoku J; Braunstein SL; Spencer EC; Khuwaja S; Wejnert C; J Acquir Immune Defic Syndr; 2020 Dec; 85(4):430-435. PubMed ID: 33136740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]